SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-103352
Filing Date
2018-03-30
Accepted
2018-03-30 16:12:03
Documents
5
Period of Report
2018-03-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d560535d8k.htm 8-K 19064
2 EX-10.1 d560535dex101.htm EX-10.1 132331
3 EX-10.2 d560535dex102.htm EX-10.2 62827
4 EX-10.3 d560535dex103.htm EX-10.3 64329
5 EX-10.4 d560535dex104.htm EX-10.4 48378
  Complete submission text file 0001193125-18-103352.txt   328511
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 18726250
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services